Discontinued — last reported Q4 '25
Crown Castle Impairment Charges decreased by 25.0% to $3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 50.0%, from $2.00M to $3.00M. Over 4 years (FY 2021 to FY 2025), Impairment Charges shows a downward trend with a -14.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High impairment charges suggest poor capital allocation or a decline in the competitive value of the company's assets.
Impairment charges are non-cash write-downs taken when the carrying value of an asset exceeds its fair market value. Thi...
Common in industries with high intangible asset bases, such as pharma and consumer goods.
impairment_charges_cf| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.00M | $0.00 | $12.00M | $14.00M | $9.00M | $3.00M | $8.00M | $0.00 | $22.00M | $8.00M | $3.00M | $6.00M | $3.00M | $15.00M | -$4.98B | $2.00M | $2.00M | $3.00M | $4.00M | $3.00M |
| QoQ Change | — | -100.0% | — | +16.7% | -35.7% | -66.7% | +166.7% | -100.0% | — | -63.6% | -62.5% | +100.0% | -50.0% | +400.0% | <-999% | +100.0% | +0.0% | +50.0% | +33.3% | -25.0% |
| YoY Change | — | — | — | — | +50.0% | — | -33.3% | -100.0% | +144.4% | +166.7% | -62.5% | — | -86.4% | +87.5% | <-999% | -66.7% | -33.3% | -80.0% | +100.1% | +50.0% |